Pills & the Public Purse: The Routes to National Drug Insurance
University of California Press, Jan 1, 1981 - Political Science - 232 pages
Examines controversial issues in the drug industry, including generic drugs, new drug licensing, and the changes national health insurance may promote
What people are saying - Write a review
We haven't found any reviews in the usual places.
adverse drug reaction American Medical Association antibiotics approved beneficiaries Bioavailability brand brand-name product California charge cians cimetidine clinical pharmacists co-payment community pharmacies covered Department of Health developed diagnosis disease dispensing fee dosage forms drug companies drug costs drug coverage drug expenditures drug experts drug industry Drug Insurance Conference drug insurance program drug lag drug products drug therapy drug utilization review effective elderly Estrogen expensive FDA's formulary generic-name products groups hypertension Ibid infections irrational prescribing Journal Lee Morse low-cost Lydecker macists manufacturer Medicaid Medicaid programs Medicare Medicine million National Drug Insurance national health insurance out-of-hospital outpatient patient cost-sharing penicillin percent personal communication phar physi physicians Pills PPIs prescribing patterns prescription drugs problem Profits psychoactive drugs reimbursement Report represent RxTF substitution therapeutic third-party tion treatment U.S. Department U.S. Government Printing United vaccine Vincent Gardner Washington